Troponin may become the "gold-standard" heart attack diagnostic tool
This article was originally published in Clinica
Executive Summary
The cardiac marker troponin could soon replace creatine kinase-MB (CK-MB) as the new "gold standard" biochemical test for diagnosing heart attack in the US. By improving a doctor's ability to evaluate patients who come to emergency rooms with chest pain, serial tests for troponin could help reduce deaths and cut down on costs associated with malpractice suits and unnecessary hospital admissions.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.